作者: Adele O. Kraft
DOI: 10.1002/CNCY.21870
关键词:
摘要: The use of minimally invasive procedures for diagnosis and treatment decisions means that very often cytological samples are the only material available testing. Cytology has evolved from a strictly morphological approach to routine immunohistochemistry. advent personalized medicine increased demand molecular testing, making rapid on-site evaluation even more relevant. This article presents current practice patterns in different settings, with special focus on variety professionals involved. Technological advances such as telepathology can help alleviate distance constraints. also provides an overview telecytopathology, describing challenges its implementation how address them. Issues hardware, personnel training, communication, guidelines, validation, use, future directions highlighted. Cancer Cytopathol 2017;125(6 suppl):449-54. © 2017 American Society.